Xylem (XYL) Cost of Revenue (2010 - 2026)

Xylem's Cost of Revenue history runs 17 years deep, the most recent figure standing at $1.4 billion for Q2 2026.

• In Q2 2026, Cost of Revenue fell 2.56% year-over-year to $1.4 billion; the TTM figure through Jun 2026 stood at $5.5 billion (up 2.14% YoY), while the FY2025 annual figure was $5.6 billion, up 3.93% from the prior year.
• Cost of Revenue for Q2 2026 stood at $1.4 billion, up from $1.3 billion in the prior quarter.
• The five-year high for Cost of Revenue was $1.5 billion in Q4 2025, with the low at $805.0 million in Q1 2022.
• The 5-year median for Cost of Revenue is $1.3 billion (2023), against an average of $1.2 billion.
• The sharpest annual moves came in 2023 and 2026: Cost of Revenue jumped 53.27% in 2023, then dropped 2.56% in 2026.
• Xylem's Cost of Revenue stood at $933.0 million in 2022, then jumped by 45.98% to $1.4 billion in 2023, then rose by 2.72% to $1.4 billion in 2024, then rose by 4.72% to $1.5 billion in 2025, then retreated by 6.28% to $1.4 billion in 2026.
• Business Quant data shows XYL's Cost of Revenue at $1.4 billion in Q2 2026, $1.3 billion in Q1 2026, and $1.5 billion in Q4 2025.